SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-056948
Filing Date
2010-11-08
Accepted
2010-11-08 17:17:26
Documents
11
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-17546_110q.htm 10-Q 1565798
2 EX-31.1 a10-17546_1ex31d1.htm EX-31.1 11048
3 EX-31.2 a10-17546_1ex31d2.htm EX-31.2 11680
4 EX-32.1 a10-17546_1ex32d1.htm EX-32.1 6827
5 EX-32.2 a10-17546_1ex32d2.htm EX-32.2 6144
  Complete submission text file 0001104659-10-056948.txt   4999441

Data Files

Seq Description Document Type Size
6 EX-101.INS amag-20100930.xml EX-101.INS 698453
7 EX-101.SCH amag-20100930.xsd EX-101.SCH 17550
8 EX-101.CAL amag-20100930_cal.xml EX-101.CAL 44054
9 EX-101.LAB amag-20100930_lab.xml EX-101.LAB 221734
10 EX-101.PRE amag-20100930_pre.xml EX-101.PRE 110547
11 EX-101.DEF amag-20100930_def.xml EX-101.DEF 74956
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 101173314
SIC: 2835 In Vitro & In Vivo Diagnostic Substances